Danaher Corporation
DHR · Healthcare · Life Sciences Tools & Services
Updated 27 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #72 of 500 by Iconic Score · #11 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Danaher Corporation (DHR) is a global leader in the Healthcare sector, specifically within Life Sciences Tools & Services, with a market capitalization of $125.9 billion. The company develops and manufactures a diverse range of innovative products and solutions that enhance the efficiency and effectiveness of life sciences research, diagnostics, and environmental monitoring. Danaher's strong portfolio includes well-known brands such as Beckman Coulter, Leica Microsystems, and Pall Corporation, positioning it as a key player in the healthcare market. The company's commitment to continuous improvement and its robust acquisition strategy have enabled it to maintain a competitive edge, driving advancements in scientific research and healthcare delivery. Danaher’s focus on innovation and operational excellence underscores its significance in addressing critical challenges in health and environmental sectors, making it a pivotal entity in the ongoing evolution of life sciences.
IconicOracleAI™ Brief
Danaher Corp's Iconic Score of 65 reflects a solid brand presence, bolstered by a strong visibility signal of 85/100 from logo analysis. Recent headlines indicate positive sentiment following a 4% jump in stock price due to a Q3 earnings beat, highlighting improving trends across its end markets. Despite a broader decline in healthcare stocks, Danaher's performance and brand recognition remain strong, contributing to its current score.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.